ARE - Alexandria Real Estate Equities

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0152711091

Life Science, Real Estate, Research Facilities, Offices, Laboratories

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a leading life science real estate investment trust (REIT) that has made a significant impact on the world since its founding in 1994. As a pioneer in the life science real estate niche, the company has established itself as the premier owner, operator, and developer of collaborative life science mega campuses in top innovation hubs across North America.

With a market capitalization of $34.4 billion, Alexandria's portfolio consists of 74.1 million square feet of properties, including 42.2 million square feet of operating properties, 5.3 million square feet of properties under construction, and a pipeline of future development projects. The company's properties are strategically located in AAA innovation cluster locations, such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.

Alexandria's unique business model focuses on creating dynamic and collaborative environments that foster innovation, productivity, and success among its tenants. The company's properties are designed to provide tenants with access to cutting-edge facilities, state-of-the-art amenities, and a network of like-minded companies and researchers. This approach has enabled Alexandria to attract a high-quality and diverse tenant base, resulting in higher occupancy levels, longer lease terms, and higher rental income.

In addition to its real estate business, Alexandria also provides strategic capital to transformative life science companies through its venture capital platform. This platform enables the company to support innovative startups and early-stage companies, further solidifying its position as a leader in the life science industry.

With a proven track record of developing Class A/A+ properties and a commitment to making a positive and lasting impact on the world, Alexandria Real Estate Equities, Inc. is well-positioned for continued growth and success in the life science real estate market. For more information, please visit https://www.are.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for ARE - Alexandria Real Estate Equities

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for ARE - Alexandria Real Estate Equities

ARE Stock Overview

Market Cap in USD 21,897m
Sector Real Estate
Industry REIT - Office
GiC SubIndustry Diversified REITs
TER 0.00%
IPO / Inception 1997-05-27

ARE Stock Ratings

Growth 5y -4.61
Fundamental -4.50
Dividend 65.9
Rel. Performance vs Sector -0.84
Analysts 4.62/5
Fair Price Momentum 113.96 USD
Fair Price DCF 34.48 USD

ARE Dividends

Dividend Yield 12m 4.27%
Yield on Cost 5y 4.13%
Dividends CAGR 5y 4.40%
Payout Consistency 95.8%

ARE Growth Ratios

Growth 12m -1.77%
Growth Correlation 12m 27%
Growth Correlation 3m 8%
CAGR 5y -0.67%
CAGR/Mean DD 5y -0.03
Sharpe Ratio 12m -0.21
Alpha vs SP500 12m -23.54
Beta vs SP500 5y weekly 1.06
ValueRay RSI 34.26
Volatility GJR Garch 1y 33.10%
Price / SMA 50 0.55%
Price / SMA 200 3.01%
Current Volume 920.1k
Average Volume 20d 920.6k

External Links for ARE Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of ARE stocks?
As of July 27, 2024, the stock is trading at USD 118.92 with a total of 920,099 shares traded.
Over the past week, the price has changed by -5.02%, over one month by +3.96%, over three months by +3.46% and over the past year by -1.12%.
What are the forecast for ARE stock price target?
According to ValueRays Forecast Model, ARE Alexandria Real Estate Equities will be worth about 123.8 in July 2025. The stock is currently trading at 118.92. This means that the stock has a potential upside of +4.1%.
Issuer Forecast Upside
Wallstreet Target Price 143.7 20.8
Analysts Target Price 145.4 22.3
ValueRay Target Price 123.8 4.10